Production of elastase, exotoxin A, and alkaline protease in sputa during pulmonary exacerbation of cystic fibrosis in patients chronically infected by Pseudomonas aeruginosa - PubMed (original) (raw)
Production of elastase, exotoxin A, and alkaline protease in sputa during pulmonary exacerbation of cystic fibrosis in patients chronically infected by Pseudomonas aeruginosa
M C Jaffar-Bandjee et al. J Clin Microbiol. 1995 Apr.
Abstract
Secretion of Pseudomonas aeruginosa elastase, exotoxin A, and alkaline protease in sputum during bronchopulmonary exacerbations was examined in 18 cystic fibrosis patients chronically infected with this microorganism. The patients were studied during one or several exacerbation periods necessitating hospitalizations of 12 to 20 days. In all cases, P. aeruginosa was present in bronchial secretions at admission and was not eradicated after treatment. The P. aeruginosa density decreased significantly after antibiotic therapy but remained greater than 10(6) CFU/g of sputum in most cases. Significant amounts of P. aeruginosa exoproteins were measured in total homogenized bronchial secretions by immunoenzymatic assays. The detection of higher levels of exoproteins at admission, the significant decrease after treatment, and the absence of exoproteins during intercrisis phases constituted arguments for a renewal of virulence of P. aeruginosa during exacerbations. Nevertheless, the concomitant changes in bacteria load and the triggering of the inflammatory process and immune complex formation could also contribute to pulmonary exacerbations.
Similar articles
- [Production of elastase, exotoxin A and alkaline protease during bronchopulmonary exacerbations in patients with mucoviscidosis chronically infected by Pseudomonas aeruginosa].
Jaffar-Bandjee MC, Carrere J, Bally M, Chazalette JP, Galabert C. Jaffar-Bandjee MC, et al. Pathol Biol (Paris). 1994 May;42(5):505-9. Pathol Biol (Paris). 1994. PMID: 7824322 French. - Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis.
Hollsing AE, Granström M, Vasil ML, Wretlind B, Strandvik B. Hollsing AE, et al. J Clin Microbiol. 1987 Oct;25(10):1868-74. doi: 10.1128/jcm.25.10.1868-1874.1987. J Clin Microbiol. 1987. PMID: 3117842 Free PMC article. - Immunoenzymometric assays for alkaline protease and exotoxin A from Pseudomonas aeruginosa: development and use in detecting exoproteins in clinical isolates from patients with cystic fibrosis.
Jaffar-Bandjee MC, Carrère J, Bally M, Guy-Crotte O, Galabert C. Jaffar-Bandjee MC, et al. Eur J Clin Chem Clin Biochem. 1994 Dec;32(12):893-9. doi: 10.1515/cclm.1994.32.12.893. Eur J Clin Chem Clin Biochem. 1994. PMID: 7696436 - Biology of Pseudomonas aeruginosa in relation to pulmonary infection in cystic fibrosis.
Pitt TL. Pitt TL. J R Soc Med. 1986;79 Suppl 12(Suppl 12):13-8. J R Soc Med. 1986. PMID: 2425090 Free PMC article. Review. No abstract available. - The role of proteases and exotoxin A in the pathogenicity of Pseudomonas aeruginosa infections.
Wretlind B, Pavlovskis OR. Wretlind B, et al. Scand J Infect Dis Suppl. 1981;29:13-9. Scand J Infect Dis Suppl. 1981. PMID: 6797058 Review.
Cited by
- Furin as a therapeutic target in cystic fibrosis airways disease.
Douglas LEJ, Reihill JA, Montgomery BM, Martin SL. Douglas LEJ, et al. Eur Respir Rev. 2023 May 3;32(168):220256. doi: 10.1183/16000617.0256-2022. Print 2023 Jun 30. Eur Respir Rev. 2023. PMID: 37137509 Free PMC article. Review. - Calprotectin-Mediated Zinc Chelation Inhibits Pseudomonas aeruginosa Protease Activity in Cystic Fibrosis Sputum.
Vermilyea DM, Crocker AW, Gifford AH, Hogan DA. Vermilyea DM, et al. J Bacteriol. 2021 Jun 8;203(13):e0010021. doi: 10.1128/JB.00100-21. Epub 2021 Jun 8. J Bacteriol. 2021. PMID: 33927050 Free PMC article. - N-Acyl Homoserine Lactone-Mediated Quorum Sensing Regulates Species Interactions in Multispecies Biofilm Communities.
Subramoni S, Muzaki MZBM, Booth SCM, Kjelleberg S, Rice SA. Subramoni S, et al. Front Cell Infect Microbiol. 2021 Mar 18;11:646991. doi: 10.3389/fcimb.2021.646991. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 33869078 Free PMC article. - Antibodies Against Pseudomonas aeruginosa Alkaline Protease Directly Enhance Disruption of Neutrophil Extracellular Traps Mediated by This Enzyme.
Jing C, Liu C, Liu Y, Feng R, Cao R, Guan Z, Xuan B, Gao Y, Wang Q, Yang N, Ma Y, Lan L, Feng J, Shen B, Wang H, Yu Y, Yang G. Jing C, et al. Front Immunol. 2021 Mar 31;12:654649. doi: 10.3389/fimmu.2021.654649. eCollection 2021. Front Immunol. 2021. PMID: 33868297 Free PMC article. - Predicting Antibiotic-Associated Virulence of Pseudomonas aeruginosa Using an ex vivo Lung Biofilm Model.
Hassan MM, Harrington NE, Sweeney E, Harrison F. Hassan MM, et al. Front Microbiol. 2020 Sep 2;11:568510. doi: 10.3389/fmicb.2020.568510. eCollection 2020. Front Microbiol. 2020. PMID: 32983077 Free PMC article.
References
- Acta Pathol Microbiol Scand B Microbiol Immunol. 1974 Aug;82(4):541-50 - PubMed
- Clin Rev Allergy. 1991 Spring-Summer;9(1-2):87-102 - PubMed
- APMIS. 1992 Apr;100(4):326-34 - PubMed
- J Med Microbiol. 1993 Jan;38(1):29-33 - PubMed
- Microbiol Immunol. 1992;36(11):1113-8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical